International Business Machines (IBM), US4592001014

IBM stock falls after $1 billion Chips Act award and trimmed 2026 outlook

Published on 09/17/2026 at 14:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IBM stock closed at USD 237.49 on September 16, 2026, down 4.38 percent after investors weighed a $1 billion Chips Act award for its Anderon unit. The shares trade around USD 237, below the USD 332.46 52-week high, as guidance for 2026 revenue growth was cut to 4-5 percent.

Photorealistic view down a long enterprise mainframe data center corridor, tall black server cabinets lined with glowing blue LED strips on both sides, cool blue ambient light reflecting off the polished floor, deep perspective showing the aisle vanishing — IBM zeigt ein großes Mainframe Rechenzentrum mit intensiver blauer Beleuchtung und Serverreihen US4592001014, Illustration mit AI erstellt.

International Business Machines Corporation stock (ISIN US4592001014) closed at USD 237.49 on the New York Stock Exchange on September 16, 2026, a drop of 4.38 percent from the previous session as investors digested a major Chips Act grant and a more cautious revenue outlook for 2026.

Chips Act award and revenue outlook move IBM stock

According to Dow Jones Newswires on September 17, 2026, Anderon, an IBM chip subsidiary, finalized a USD 1 billion research and development award from the United States Commerce Department under the 2022 Chips and Science Act, underscoring the company’s strategic push in semiconductors and quantum technologies.

As Stocktwits News reported on September 16, 2026, IBM’s management trimmed its full-year 2026 constant-currency revenue growth outlook to a range of 4 to 5 percent, down from a previous expectation of more than 5 percent, after second-quarter revenue came in slightly below analysts’ forecasts.

In that same report, IBM’s second-quarter 2026 revenue was stated at USD 17.16 billion, up around 1 percent year over year, but short of the USD 17.26 billion consensus estimate, while adjusted earnings per share stood at USD 2.93, matching analyst expectations and improving from USD 2.80 in the prior-year quarter.

Latest earnings figures and margin profile

International Business Machines’ most recent quarterly results, for the second quarter of 2026, show the company maintaining profitability despite mixed top-line trends. According to MarketBeat on September 17, 2026, IBM reported quarterly earnings per share of USD 2.93 in that period, exactly in line with consensus, on revenue of USD 17.16 billion, which was below expectations of USD 17.46 billion but still represented a 1.1 percent increase compared with the same quarter a year earlier.

The same MarketBeat summary notes that IBM achieved a return on equity of 35.65 percent and a net margin of 15.52 percent in the latest quarter, highlighting the company’s ability to generate solid profitability from its revenue base despite a modest revenue miss relative to analyst forecasts.

Year-over-year, earnings per share in the quarter rose from USD 2.80 to USD 2.93, while revenue moved from roughly USD 16.97 billion to USD 17.16 billion, illustrating incremental growth even as management takes a more conservative stance on the pace of full-year 2026 expansion.

Analyst stance and valuation context

Investor reaction to the combination of the Chips Act grant and the lower revenue growth outlook has been mixed, but Wall Street’s longer-term view on IBM remains broadly constructive. As Yahoo Finance reported on September 16, 2026, several analysts continue to rate IBM shares as a buy or moderate buy and see the year-to-date pullback as overdone, pointing to price targets that stretch as high as USD 365 and therefore imply roughly 45 percent upside from the current price region.

According to data cited by MarketBeat on September 17, 2026, IBM stock presently carries an average analyst rating of Moderate Buy with a consensus target price of USD 265.16, which stands about 11.6 percent above the USD 237.49 closing price on September 16, 2026.

This gap between the market price and the consensus target suggests that, despite near-term pressure following the revenue guidance cut, analysts still expect IBM to deliver enough growth and cash flow from areas such as software, consulting and hybrid cloud to justify a higher valuation over the coming 12 months.

Price performance, volatility and technical backdrop

Per data from CNBC, IBM shares finished regular trading at USD 237.49 on September 16, 2026, representing a one-day loss of USD 10.88 or 4.38 percent, before trading around USD 238.50 in after-hours dealings later that day.

According to a MarketBeat overview referenced in several institutional holdings notes dated September 17, 2026, International Business Machines stock has a 52-week low of USD 199.19 and a 52-week high of USD 332.46, placing the latest closing price roughly 19.3 percent above the low but about 28.6 percent below the high, a range that signals both recovery from earlier troughs and substantial room before prior peaks are revisited.

Technical analysis published by FXEmpire on September 17, 2026, shows IBM’s daily momentum indicator at 8.26 with several simple and exponential moving averages on 10- to 50-day windows signaling a buy, suggesting that, despite the latest pullback, the broader short-term trend remains upward in their model.

Risks investors are watching

The immediate risk investors are weighing is that slower constant-currency revenue growth in 2026 could limit upside from the current valuation, particularly if infrastructure and hardware sales continue to decline, as they did in the latest quarter when infrastructure revenue fell 7 percent year over year while software revenue grew 5 percent and consulting was flat, according to Stocktwits News.

Broader macroeconomic conditions also play a role: as The Straits Times reported on September 17, 2026, IBM fell around 4.4 percent amid a broader selloff on Wall Street after the Federal Reserve raised interest rates and signaled the possibility of further tightening, an environment that can pressure valuation multiples for dividend-paying blue-chip technology names.

For shareholders, the interplay between solid margins and cash generation on one side and a more cautious revenue trajectory on the other will likely remain central to the investment case, especially as the company deploys the USD 1 billion Chips Act grant to support long-term semiconductor and quantum computing research.

IBM stock price and key figures as of the latest close

IBM stock’s reference price in this article is the September 16, 2026, New York Stock Exchange closing level of USD 237.49, with the shares having traded between the 52-week low of USD 199.19 and the 52-week high of USD 332.46 over the past year, and carrying a consensus analyst target of USD 265.16 that sits modestly above the latest close.